Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province (IFS) (IFS)

April 2, 2024 updated by: Lingai Pan, Sichuan Provincial People's Hospital
The goal of this survey is to learn about the current status of the diagnosis and treatment of invasive fungal infections among intensive care physicians in Sichuan Province (IFS). Its primary focus lies on answering the following questions: ①awareness and proficiency in diagnosis and treatment; ②the use of antifungal medications; ③the application of microbiological identification and diagnostic methods. We aim to analyze the problems and deficiencies that existed among intensive care physicians in order to provide a basis for the development of targeted training and intervention measures.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

300

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Intensive care physicians in medical institutions at all levels in Sichuan Province. Anticipated total of 20 centers will participate in the study, with a total of 300 physicians to be included in the survey.

Description

Inclusion Criteria:

  • Intensive care physicians in medical institutions at all levels in Sichuan Province

Exclusion Criteria:

  • Exclude non-Sichuan physicians.
  • Excluding physicians who are not engaged in intensive care unit.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The survey on the hospital's diagnostic and treatment standards and infrastructure for invasive fungal infections
Time Frame: From enrollment to the end of survey at 16 weeks

①To investigate the basic knowledge and skill mastery of invasive fungi diagnosis and treatment by intensive care physicians in Sichuan province, including information on pathogenesis, clinical manifestations, diagnosis, and treatment.

② To investigate the concerns and selection tendency of intensive care physicians in Sichuan province in choosing antifungal drugs in practice, including information on treatment types, drug choice, dosage, and treatment course.

From enrollment to the end of survey at 16 weeks
The survey on the awareness of an invasive fungal infection among intensive care physicians
Time Frame: From enrollment to the end of survey at 16 weeks

① To assess the application of pathogenetic detection and diagnostic methods of invasive fungal infections by intensive care physicians in Sichuan Province, including the technical level of fungal smear and culture, PCR detection, histopathological examination, and NGS.

②To analyse the problems and deficiencies in the diagnosis and treatment of invasive fungal infections among invasive care physicians in Sichuan Province, and to provide a reference basis for the development of targeted training and intervention measures.

From enrollment to the end of survey at 16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2024

Primary Completion (Estimated)

September 30, 2024

Study Completion (Estimated)

September 30, 2024

Study Registration Dates

First Submitted

March 7, 2024

First Submitted That Met QC Criteria

April 2, 2024

First Posted (Actual)

April 4, 2024

Study Record Updates

Last Update Posted (Actual)

April 4, 2024

Last Update Submitted That Met QC Criteria

April 2, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • LPan

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Invasive Fungal Infections

Subscribe